Rey Jesus Romero1, Raquel Colorado-Subizar2, Maripi De Uriarte-Lorente2, Marisol Barradas-Lagunes3, Paola Bravo-De Ávila4, Julio Jorge Romero-Espejo2. 1. Department of Bariatric and Metabolic Surgery, Covadonga Hospital, Av. 7 1610, 94560, Córdoba, Veracruz, Mexico. rey_@hotmail.com. 2. Department of Bariatric and Metabolic Surgery, Covadonga Hospital, Av. 7 1610, 94560, Córdoba, Veracruz, Mexico. 3. Department of Psychology MSc Psy, Bariatric and Metabolic Surgery Center Obesity Health, Boulevard del Mar 415, Boca del Río, 94299, Veracruz, Mexico. 4. Department of Nutrition, Bariatric and Metabolic Surgery Center Obesity Health, Boulevard del Mar 415, Boca del Río, 94299, Veracruz, Mexico.
Abstract
BACKGROUND: Single anastomosis sleeve ileal (SASI) Bypass has recently emerged as a novel surgical technique. The purpose of this study is evaluating the efficacy and feasibility of our SASI technique. METHODS: Between April 2018 and February 2020, 83 patients underwent SASI bypass at our center. A retrospective analysis was performed. Forty-three patients (51.8%) completed follow-up at 12 months. RESULTS: Average BMI at 12 months, change in BMI, and %EWL were 28.2 ± 4.5 kg/m2, 13.5 ± 5.7 kg/m2, and 85.6% respectively. From the 25 patients evaluated, diabetes remission occurred in 95.8% of them. There were 4 (4.8%) Clavien-Dindo (CD) I, 5 (6.0%) CD II, and 2 (2.4%) CD IIIb complications. CONCLUSIONS: SASI bypass offers excellent weight loss and comorbidities resolution. As expected, higher-quality studies are needed.
BACKGROUND: Single anastomosis sleeve ileal (SASI) Bypass has recently emerged as a novel surgical technique. The purpose of this study is evaluating the efficacy and feasibility of our SASI technique. METHODS: Between April 2018 and February 2020, 83 patients underwent SASI bypass at our center. A retrospective analysis was performed. Forty-three patients (51.8%) completed follow-up at 12 months. RESULTS: Average BMI at 12 months, change in BMI, and %EWL were 28.2 ± 4.5 kg/m2, 13.5 ± 5.7 kg/m2, and 85.6% respectively. From the 25 patients evaluated, diabetes remission occurred in 95.8% of them. There were 4 (4.8%) Clavien-Dindo (CD) I, 5 (6.0%) CD II, and 2 (2.4%) CD IIIb complications. CONCLUSIONS: SASI bypass offers excellent weight loss and comorbidities resolution. As expected, higher-quality studies are needed.
Entities:
Keywords:
Bariatric surgery; Bipartition; Diabetes; Metabolic surgery; SASI bypass; Single anastomosis sleeve ileal; Surgery
Authors: Sérgio Santoro; Carlos E Malzoni; Manoel C P Velhote; Fábio Q Milleo; Marco A Santo; Sidney Klajner; Durval Damiani; João G Maksoud Journal: Obes Surg Date: 2006-10 Impact factor: 4.129
Authors: Piotr Kalinowski; Rafał Paluszkiewicz; Tadeusz Wróblewski; Piotr Remiszewski; Mariusz Grodzicki; Zbigniew Bartoszewicz; Marek Krawczyk Journal: Surg Obes Relat Dis Date: 2016-08-18 Impact factor: 4.734
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: Kamal K Mahawar; Jacques Himpens; Scott A Shikora; Jean-Marc Chevallier; Mufazzal Lakdawala; Maurizio De Luca; Rudolf Weiner; Ali Khammas; Kuldeepak Singh Kular; Mario Musella; Gerhard Prager; Mohammad Khalid Mirza; Miguel Carbajo; Lilian Kow; Wei-Jei Lee; Peter K Small Journal: Obes Surg Date: 2018-02 Impact factor: 4.129